Global S&T Development Trend Analysis Platform of Resources and Environment
DOI | 10.1126/science.aai8128 |
IgG antibodies to dengue enhanced for Fc gamma RIIIA binding determine disease severity | |
Wang, Taia T.1,2; Sewatanon, Jaturong3,4,5; Memoli, Matthew J.6; Wrammert, Jens4,7; Bournazos, Stylianos1; Bhaumik, Siddhartha Kumar4,7; Pinsky, Benjamin A.2,8; Chokephaibulkit, Kulkanya9; Onlamoon, Nattawat10; Pattanapanyasat, Kovit10; Taubenberger, Jeffery K.6; Ahmed, Rafi3,4; Ravetch, Jeffrey V.1 | |
2017-01-27 | |
发表期刊 | SCIENCE
![]() |
ISSN | 0036-8075 |
EISSN | 1095-9203 |
出版年 | 2017 |
卷号 | 355期号:6323页码:395-+ |
文章类型 | Article |
语种 | 英语 |
国家 | USA; Thailand |
英文摘要 | Dengue virus (DENV) infection in the presence of reactive, non-neutralizing immunoglobulin G (IgG) (RNNIg) is the greatest risk factor for dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS). Progression to DHF/DSS is attributed to antibody-dependent enhancement (ADE); however, because only a fraction of infections occurring in the presence of RNNIg advance to DHF/DSS, the presence of RNNIg alone cannot account for disease severity. We discovered that DHF/DSS patients respond to infection by producing IgGs with enhanced affinity for the activating Fc receptor Fc gamma RIIIA due to afucosylated Fc glycans and IgG1 subclass. RNNIg enriched for afucosylated IgG1 triggered platelet reduction in vivo and was a significant risk factor for thrombocytopenia. Thus, therapeutics and vaccines restricting production of afucosylated, IgG1 RNNIg during infection may prevent ADE of DENV disease. |
领域 | 地球科学 ; 气候变化 ; 资源环境 |
收录类别 | SCI-E |
WOS记录号 | WOS:000393172800039 |
WOS关键词 | VIRUS-INFECTION ; HEMORRHAGIC-FEVER ; DEPENDENT ENHANCEMENT ; IN-VITRO ; CORRELATE ; RECEPTOR ; SEROTYPE ; PATHOGENESIS ; POLYMORPHISM ; MACROPHAGES |
WOS类目 | Multidisciplinary Sciences |
WOS研究方向 | Science & Technology - Other Topics |
URL | 查看原文 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://119.78.100.173/C666/handle/2XK7JSWQ/195307 |
专题 | 地球科学 资源环境科学 气候变化 |
作者单位 | 1.Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10065 USA; 2.Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; 3.Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; 4.Emory Univ, Emory Vaccine Ctr, Sch Med, Atlanta, GA 30322 USA; 5.Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand; 6.Natl Inst Hlth, Natl Inst Allergy & Infect Dis, Infect Dis Lab, Viral Pathogenesis & Evolut Sect, Bethesda, MD USA; 7.Emory Univ, Sch Med, Dept Pediat, Div Infect Dis, Atlanta, GA 30322 USA; 8.Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; 9.Mahidol Univ, Siriraj Hosp, Fac Med, Dept Paediat, Bangkok 10700, Thailand; 10.Mahidol Univ, Siriraj Hosp, Fac Med, Dept Res & Dev, Bangkok 10700, Thailand |
推荐引用方式 GB/T 7714 | Wang, Taia T.,Sewatanon, Jaturong,Memoli, Matthew J.,et al. IgG antibodies to dengue enhanced for Fc gamma RIIIA binding determine disease severity[J]. SCIENCE,2017,355(6323):395-+. |
APA | Wang, Taia T..,Sewatanon, Jaturong.,Memoli, Matthew J..,Wrammert, Jens.,Bournazos, Stylianos.,...&Ravetch, Jeffrey V..(2017).IgG antibodies to dengue enhanced for Fc gamma RIIIA binding determine disease severity.SCIENCE,355(6323),395-+. |
MLA | Wang, Taia T.,et al."IgG antibodies to dengue enhanced for Fc gamma RIIIA binding determine disease severity".SCIENCE 355.6323(2017):395-+. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论